With the expansion of new technologies and limited resources, the
healthcare market demands timely and rigorous outcomes studies to
justify access and reimbursements of new technologies including
pharmaceutical products. BBC provides high quality research capability
and timely professional services for biomedical and pharmaceutical
industry to enhance product values. Our value-added services enable
these industries and government decision-makers to rationally allocate
limited resources including pharmaceutical products, medical devices,
and disease management capacity in order to achieve maximum market and
social effects.
Service
-
Burden of illness study
-
Disease epidemiology and nature progression model
-
Cost-effectiveness analyses and full scale economic model
-
Economic evaluations with clinical trial data
-
Budgetary impact model
-
Pricing analysis and reimbursement dossier
-
Retrospective database analysis
-
Patient reported outcomes researches (QOL, preference, satisfaction etc.)
-
Comprehensive literature synthesis
-
Contact us for more information if you have specific needs...
BBC Training
Released training courses on outcomes research and management:
* Click "here" for all BBC training courses
Advisors
|
Abraham G. Hartzema, MSPH, PhD, FISPE
Professor and Eminent Scholar
Perry A. Foote Chair in Health Outcomes Research and Pharmacoeconomics
Department of Pharmacy Health Care Administration
University of Florida, College of Pharmacy |
|
|
C. Daniel Mullins, MA, PhD
Professor, Chair, Department of Phamaceutical Health Services Research
University of Maryland, School of Pharmacy |
|
|
Gordon G. Liu, PhD
Associate Professor
Director of Graduate Studies
Department of Pharmaceutical Policy and Evaluative Science
University of North Carolina at Chapel Hill
Chair, Department of Health Economics and Management, Peking University |
|
|
|
|
Link to "Services" for more information.